Evidence map›Paper›PMID 39723034›Full record

ArticleFood science & nutrition2024

Advance Glycation End Products Inhibition by

Muhammad Fakhar Ul Mehmood, Marvi, Hatem A Abuelizz, Nighat Aziz, Raheela Bano, Asif Wazir, Imran Ahmad, Khizar Abbas, Saiqa Ishtiaq, Adnan Amin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhammad Fakhar Ul MehmoodDepartment of Pharmacology, Faculty of Pharmacy University of Balochistan Quetta Pakistan.
MarviDepartment of Pharmacology, Faculty of Pharmacy University of Balochistan Quetta Pakistan.
Hatem A AbuelizzDepartment of Pharmaceutical Chemistry, College of Pharmacy King Saud University Riyadh Saudi Arabia.
Nighat AzizDepartment of Pharmacology Gomal Medical College Dera Ismail Khan Khyber Pakhtunkhwa Pakistan.
Raheela BanoDepartment of Pathology Gomal Medical College Dera Ismail Khan Khyber Pakhtunkhwa Pakistan.
Asif WazirDepartment of Pharmacognosy Bahauddin Zakariya University Multan Pakistan.
Imran AhmadDepartment of Pharmaceutical Chemistry Bahauddin Zakariya University Multan Pakistan.
Khizar AbbasDepartment of Pathology Gomal Medical College Dera Ismail Khan Khyber Pakhtunkhwa Pakistan.ORCID https://orcid.org/0000-0001-7343-078X
Saiqa IshtiaqCentre for Study of Human Health Emory University Atlanta Georgia USA.
Adnan AminNPRL, Department of Pharmacognosy, Faculty of Pharmacy Gomal University Dera Ismail Khan Khyber Pakhtunkhwa Pakistan.ORCID https://orcid.org/0000-0001-5562-6703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advance glycation end products (AGEs) are the main reason for diabetic complications. Persistent hyperglycemia and non-enzymatic glycation increase the rate of AGEs formation. Natural functional food-based approaches are mainly under investigation these days to discover new treatment options. We focused to investigate potential of medium polar fractions of

Indexed as

AGEsantioxidantCitrus Spp.medium polarpolymethoxylated flavonoids

Identifiers

PMID39723034
PMCPMC11666926

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.